[The action of an alpha-adrenergic stimulator (methoxamine) on the pituitary system].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism; D000328:Adult; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism; D008729:Methoxamine / Q000008:administration & dosage / Q000494:pharmacology*; D010906:Pituitary Hormone-Releasing Hormones / Q000378:metabolism; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012636:Secretory Rate / Q000187:drug effects; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism
D010906:Pituitary Hormone-Releasing Hormones; D011941:Receptors, Adrenergic; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D003346:Corticotropin-Releasing Hormone; D008729:Methoxamine
Osservazioni sull'azione di uno stimolante alfa-adrenergico (methoxamina) sull'asse ipofiso-corticosurrenalico